Healthcare - Biotechnology - NASDAQ - US
$ 0.211
-12.4 %
$ 3.91 M
Market Cap
-0.02
P/E
CASH FLOW STATEMENT
-11.7 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
6 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Aptevo Therapeutics Inc.
| Net Income | -17.4 M |
| Depreciation & Amortization | 567 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 2.19 M |
| Change in Working Capital | 2.91 M |
| Others | -97 K |
| Free Cash Flow | -11.7 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (17.4) | 8.0 | (28.5) | (17.8) | (40.4) | (53.7) | 7.0 | (112.4) | (59.3) | (51.1) | (53.3) |
| Depreciation & Amortization | 0.6 | 0.9 | 1.1 | 1.4 | 2.2 | 2.4 | 3.1 | 3.4 | 2.9 | 2.0 | 0.7 |
| Deferred Income Tax | 0 | 0 | 4 K | (12.2) | (4.2) | 0 | 2 K | 71.2 | (1.4) | 0.1 | 0 |
| Stock Based Compensation | 2.2 | 1.8 | 1.6 | 1.3 | 1.6 | 2.1 | 4.9 | 3.8 | 1.1 | 1.1 | 1.0 |
| Other Operating Activities | 10 K | (33.9) | 6.6 | 0.4 | 0.7 | 1.0 | (52.1) | (16.7) | 3.7 | 0.3 | 18 K |
| Change in Working Capital | 2.9 | 2.1 | (2.7) | (2.4) | (2.2) | (3.3) | (4.5) | 13.8 | 4.2 | 0.6 | 0.3 |
| Cash From Operations | (11.7) | (21.0) | (21.7) | (29.3) | (42.4) | (51.4) | (41.6) | (36.9) | (48.8) | (47.0) | (51.4) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | 0 | 29 K | (0.7) | 88 K | (0.2) | (1.0) | (1.4) | (2.5) | (1.5) | (1.0) | (1.0) |
| Other Items | 0 | 0 | 0 | 28.1 | 4.2 | 73.8 | 30.9 | (44.9) | 0 | (47.8) | 0 |
| Cash From Investing Activities | 0 | 29 K | (0.7) | 28.0 | 4.1 | 72.8 | 29.5 | (47.4) | (1.5) | (48.8) | (1.0) |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 11 K | 0 | 0 | (0.8) | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (3.5) | (12.3) | (10.6) | 2.6 | (0.1) | 0 | 0 | 18.0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.0 | 2.7 | 26.5 | 21.2 | 58 K | (1.4) | 19.5 | 71.2 | 51.3 | 99.4 | 52.4 |
| Cash From Financing Activities | 6.0 | (2.6) | 26.2 | 23.9 | 20.1 | (0.8) | 9.5 | 89.3 | 51.3 | 99.4 | 52.4 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | (5.7) | (23.7) | 3.8 | 22.6 | (18.1) | 20.6 | (2.6) | 5.0 | 1.0 | 3.6 | 0 |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | (11.7) | (21.1) | (22.4) | (29.4) | (42.5) | (52.4) | (43.0) | (39.4) | (50.3) | (48.0) | (52.4) |